Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lulzim Shkreta

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Molecular and Cellular Biology|October 10, 2007
Protein kinase C-dependent control of Bcl-x alternative splicingTimothée Revil, Johanne Toutant, Lulzim Shkreta, et al.
The Journal of Biological Chemistry|October 29, 2010
The DNA damage response pathway regulates the alternative splicing of the apoptotic mediator Bcl-xLulzim Shkreta, Laetitia Michelle, Johanne Toutant, et al.
Cell Reports|November 17, 2016
SRSF10 Connects DNA Damage to the Alternative Splicing of Transcripts Encoding Apoptosis, Cell-Cycle Control, and DNA Repair FactorsLulzim Shkreta, Johanne Toutant, Mathieu Durand, et al.
Scientific Reports|February 4, 2018
hnRNP A1/A2 and Sam68 collaborate with SRSF10 to control the alternative splicing response to oxaliplatin-mediated DNA damageAlexandre Cloutier, Lulzim Shkreta, Johanne Toutant, et al.
The Journal of Biological Chemistry|June 7, 2008
Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-xPhilippe Cloutier, Johanne Toutant, Lulzim Shkreta, et al.
RNA (New York, N.Y.)|June 6, 2007
hnRNP I/PTB can antagonize the splicing repressor activity of SRp30cCaroline Paradis, Philippe Cloutier, Lulzim Shkreta, et al.
Molecular Cancer Therapeutics|June 21, 2008
Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genesLulzim Shkreta, Ulrike Froehlich, Eric R Paquet, et al.
Advances in Experimental Medicine and Biology|April 3, 2008
hnRNP proteins and splicing controlRebeca Martinez-Contreras, Philippe Cloutier, Lulzim Shkreta, et al.
Cancer Treatment and Research|November 14, 2013
Cancer-Associated Perturbations in Alternative Pre-messenger RNA SplicingLulzim Shkreta, Brendan Bell, Timothée Revil, et al.
Endocrinology|October 11, 2003
Generation of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disordersDenise D Belsham, Fang Cai, Hong Cui, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Molecular and Cellular Biology|October 10, 2007
Protein kinase C-dependent control of Bcl-x alternative splicingTimothée Revil, Johanne Toutant, Lulzim Shkreta, et al.
The Journal of Biological Chemistry|October 29, 2010
The DNA damage response pathway regulates the alternative splicing of the apoptotic mediator Bcl-xLulzim Shkreta, Laetitia Michelle, Johanne Toutant, et al.
Cell Reports|November 17, 2016
SRSF10 Connects DNA Damage to the Alternative Splicing of Transcripts Encoding Apoptosis, Cell-Cycle Control, and DNA Repair FactorsLulzim Shkreta, Johanne Toutant, Mathieu Durand, et al.
Scientific Reports|February 4, 2018
hnRNP A1/A2 and Sam68 collaborate with SRSF10 to control the alternative splicing response to oxaliplatin-mediated DNA damageAlexandre Cloutier, Lulzim Shkreta, Johanne Toutant, et al.
The Journal of Biological Chemistry|June 7, 2008
Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-xPhilippe Cloutier, Johanne Toutant, Lulzim Shkreta, et al.
RNA (New York, N.Y.)|June 6, 2007
hnRNP I/PTB can antagonize the splicing repressor activity of SRp30cCaroline Paradis, Philippe Cloutier, Lulzim Shkreta, et al.
Molecular Cancer Therapeutics|June 21, 2008
Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genesLulzim Shkreta, Ulrike Froehlich, Eric R Paquet, et al.
Advances in Experimental Medicine and Biology|April 3, 2008
hnRNP proteins and splicing controlRebeca Martinez-Contreras, Philippe Cloutier, Lulzim Shkreta, et al.
Cancer Treatment and Research|November 14, 2013
Cancer-Associated Perturbations in Alternative Pre-messenger RNA SplicingLulzim Shkreta, Brendan Bell, Timothée Revil, et al.
Endocrinology|October 11, 2003
Generation of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disordersDenise D Belsham, Fang Cai, Hong Cui, et al.
Pageof 4